BioSpace News Archive

Imara Inc., a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, announced that it has commenced a proposed underwritten public offering of $50 million of shares of its common stock.

LeMaitre Vascular, Inc., a provider of peripheral vascular devices, implants and services, announced preliminary unaudited results for the quarter ended June 30, 2021.

LeMaitre Vascular, Inc., a provider of peripheral vascular devices, implants and services, announced that it has commenced an underwritten public offering of shares of its common stock.

Genomma Lab Internacional today announced that it will report its Second Quarter 2021 results on Wednesday, July 28, 2021 after the Mexican Market (BMV) close.

Reduced average 30-day heart failure related costs by $17,753 per study subject in FUROSCIX ® arm compared to historically matched comparators.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a webcast on Tuesday, July 20, 2021 at 4:30 p.m. ET / 9:30 p.m. IST to provide an update on Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn), which was approved by the U.S. Food and Drug Administration (FDA) on June 30, 2021 .

Masimo (NASDAQ: MASI) will release second quarter 2021 financial results for the period ended July 3, 2021, after the market closes on Tuesday, July 27, 2021.

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2021 financial results before the market opens on Tuesday, July 27, 2021.

TransCode Therapeutics, Inc. today announced the closing of its initial public offering of 7,187,500 shares of its common stock at a public offering price of $4.00 per share.

Centene Corporation (NYSE: CNC) announced today an organizational enhancement approved by the Board of Directors.